HIMS & HERS HEALTH INC (HIMS) Fundamental Analysis & Valuation

NYSE:HIMS • US4330001060

Current stock price

22.825 USD
+0.8 (+3.66%)
Last:

This HIMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HIMS Profitability Analysis

1.1 Basic Checks

  • HIMS had positive earnings in the past year.
  • In the past year HIMS had a positive cash flow from operations.
  • In multiple years HIMS reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.96%, HIMS is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • The Return On Equity of HIMS (23.73%) is better than 91.00% of its industry peers.
  • HIMS has a Return On Invested Capital (5.49%) which is in line with its industry peers.
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROIC 5.49%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • HIMS has a Profit Margin of 5.47%. This is in the better half of the industry: HIMS outperforms 80.00% of its industry peers.
  • With a decent Operating Margin value of 5.18%, HIMS is doing good in the industry, outperforming 62.00% of the companies in the same industry.
  • HIMS has a better Gross Margin (73.83%) than 89.00% of its industry peers.
  • In the last couple of years the Gross Margin of HIMS has declined.
Industry RankSector Rank
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HIMS Health Analysis

2.1 Basic Checks

  • HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HIMS has been increased compared to 1 year ago.
  • Compared to 5 years ago, HIMS has more shares outstanding
  • The debt/assets ratio for HIMS is higher compared to a year ago.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • HIMS has an Altman-Z score of 3.27. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.27, HIMS is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
  • HIMS has a debt to FCF ratio of 16.94. This is a negative value and a sign of low solvency as HIMS would need 16.94 years to pay back of all of its debts.
  • HIMS has a Debt to FCF ratio of 16.94. This is in the lower half of the industry: HIMS underperforms 62.00% of its industry peers.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that HIMS has dependencies on debt financing.
  • HIMS has a Debt to Equity ratio of 1.80. This is in the lower half of the industry: HIMS underperforms 69.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Altman-Z 3.27
ROIC/WACC0.64
WACC8.58%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • HIMS has a Current Ratio of 1.90. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • HIMS has a better Current ratio (1.90) than 80.00% of its industry peers.
  • HIMS has a Quick Ratio of 1.70. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.70, HIMS is doing good in the industry, outperforming 73.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.7
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIMS Growth Analysis

3.1 Past

  • The earnings per share for HIMS have decreased by -5.56% in the last year.
  • HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.00%.
  • The Revenue has been growing by 64.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.73% yearly.
  • The Revenue is expected to grow by 14.53% on average over the next years. This is quite good.
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue Next Year17.57%
Revenue Next 2Y18.47%
Revenue Next 3Y17.87%
Revenue Next 5Y14.53%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIMS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 44.75 indicates a quite expensive valuation of HIMS.
  • Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
  • HIMS is valuated expensively when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 41.80, the valuation of HIMS can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
  • HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.75
Fwd PE 41.8
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
  • 62.00% of the companies in the same industry are cheaper than HIMS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 90.62
EV/EBITDA 28.75
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as HIMS's earnings are expected to grow with 29.50% in the coming years.
PEG (NY)6.32
PEG (5Y)N/A
EPS Next 2Y17.86%
EPS Next 3Y29.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIMS Dividend Analysis

5.1 Amount

  • No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS Fundamentals: All Metrics, Ratios and Statistics

HIMS & HERS HEALTH INC

NYSE:HIMS (3/23/2026, 10:14:09 AM)

22.825

+0.8 (+3.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners85.66%
Inst Owner Change-9.76%
Ins Owners6.6%
Ins Owner Change21.22%
Market Cap5.20B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts54.29
Price Target30 (31.43%)
Short Float %41.52%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.8%
Min EPS beat(2)-43.53%
Max EPS beat(2)71.14%
EPS beat(4)3
Avg EPS beat(4)25.02%
Min EPS beat(4)-43.53%
Max EPS beat(4)71.14%
EPS beat(8)7
Avg EPS beat(8)139.72%
EPS beat(12)10
Avg EPS beat(12)110.2%
EPS beat(16)13
Avg EPS beat(16)84.74%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-30.94%
PT rev (3m)-36.88%
EPS NQ rev (1m)-77.67%
EPS NQ rev (3m)-81.12%
EPS NY rev (1m)-6.07%
EPS NY rev (3m)-17.17%
Revenue NQ rev (1m)-5%
Revenue NQ rev (3m)-5.32%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 44.75
Fwd PE 41.8
P/S 2.22
P/FCF 90.62
P/OCF 17.34
P/B 9.62
P/tB 78.25
EV/EBITDA 28.75
EPS(TTM)0.51
EY2.23%
EPS(NY)0.55
Fwd EY2.39%
FCF(TTM)0.25
FCFY1.1%
OCF(TTM)1.32
OCFY5.77%
SpS10.3
BVpS2.37
TBVpS0.29
PEG (NY)6.32
PEG (5Y)N/A
Graham Number5.22
Profitability
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROCE 6.95%
ROIC 5.49%
ROICexc 8.2%
ROICexgc 13.77%
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
FCFM 2.45%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Debt/EBITDA 5.52
Cap/Depr 445.11%
Cap/Sales 10.33%
Interest Coverage 250
Cash Conversion 170.27%
Profit Quality 44.73%
Current Ratio 1.9
Quick Ratio 1.7
Altman-Z 3.27
F-Score5
WACC8.58%
ROIC/WACC0.64
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year17.57%
Revenue Next 2Y18.47%
Revenue Next 3Y17.87%
Revenue Next 5Y14.53%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.78%
EBIT Next 3Y70.33%
EBIT Next 5Y47.66%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 1 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


What is the profitability of HIMS stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 5 / 10.


What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.